Clinical Trials Logo

Clinical Trial Summary

The detection of miRNA (non-coding ribonucleic acid) in the blood in the context of active tuberculosis is an innovative approach to the detection of new disease-specific biomarkers. The primary goal of this analysis is to define, for the first time, an miRNA fingerprint for tuberculosis in sweat. Samples that were collected as part of the Sweatb Study (NCT03667742) project are examined for the occurrence of disease-specific, non-coding miRNAs to define new biomarkers in the sweat. These biomarkers can be detected non-invasively and will help in the detection of patients with active tuberculosis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05048381
Study type Observational
Source University Hospital, Basel, Switzerland
Contact
Status Withdrawn
Phase
Start date September 6, 2021
Completion date October 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT03271567 - Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
Not yet recruiting NCT02512484 - Improving the Detection of Active Tuberculosis in Accident and Emergency Departments N/A
Completed NCT01269268 - Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
Completed NCT06408129 - COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB)
Completed NCT02042261 - The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study N/A
Active, not recruiting NCT05045391 - Pulmonary Aspergillosis in Tuberculosis Patients
Completed NCT04048018 - Performance Evaluation of the VIDAS TB-IGRA Assay.
Recruiting NCT02639936 - New Generation IGRA in Immunocompromised Individuals N/A
Terminated NCT02898623 - Serological Test for the Diagnosis of TB